Marco Maria Germani, Roberto Moretto, Arndt Stahler, Tadayoshi Hashimoto, Federica Morano, Alan P. Venook, Sebastian Stintzing, Yoshiaki Nakamura, Giacomo Di Paolo, Francesca Battaglin, Kathrin Heinrich, Kei Muro, Francesca Bergamo, Dominik Paul Modest, Junpei Soeda, Carlotta Antoniotti, Heinz-Josef Lenz, Takayuki Yoshino, Volker Heinemann, Chiara Cremolini. "Assessing the predictive role of tumor sidedness in
            <i>RAS</i>
            and
            <i>BRAF</i>
            wild-type metastatic colorectal cancer (mCRC) treated with first-line doublets + anti-EGFRs/bevacizumab (bev) or triplet + bev: An individual patient data pooled analysis of 10 randomized clinical trials.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.3538